dsdsa

product

New Arrival China 5-Fluorouracil - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" as well as theory of "quality the basic, have faith in the initial and administration the advanced" for Daclatasvir, 1431697-94-7, 209216-23-9, Our aim is to help customers realize their goals. We are making great efforts to achieve this win-win situation and sincerely welcome you to join us.
New Arrival China 5-Fluorouracil - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai Detail:

Product name Docetaxel Trihydrate
Synonyms (αR,βS)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,hydrate (1:3)
CAS No. 148408-66-6
Appearance White to off-white crystalline powder
Molecular Formula C43H53NO14.3(H2O)
Molecular Weight 861.94
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Docetaxel Trihydrate CAS# 148408-66-6

ITEMS

STANDARDS

RESULTS

Characters A:White to off-white crystalline powder Conforms
B:Solubility :Insoluble in water ,soluble in ethanol and acetone   Conforms
Specific Rotation             ﹣38.5°~﹣41.5° ﹣40°
Identification 1.IR:  The same to check sample    Conforms
2.UV:  λmax232nm    Conforms
  1. Colour reactions: positive reactions
   Conforms
  1. HPLC: retention times is same as the standard sample
   Conforms
Impurities Total impurities: NMT 1.0% 0.29%
Impurities A: NMT 0.5% 0.0551%
Impurities B: NMT 0.3% 0.0470%
Impurities C: NMT 0.3% 0.0535%
Any other single impurity: NMT 0.1% 0.0702%
Water 5.0% – 7.0% 6.15%
Residue on ignition NMT 0.1% w/w 0.03%
Heavy metal NMT 20ppm Conforms
Assay 97.5%~ 102.0% 99.7%
Conclusion

It meets EP7.5.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

New Arrival China 5-Fluorouracil - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

New Arrival China 5-Fluorouracil - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

New Arrival China 5-Fluorouracil - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures


Related Product Guide:

Sticking for the belief of "Creating items of top of the range and creating buddies with people today from all over the world", we normally put the interest of shoppers in the first place for New Arrival China 5-Fluorouracil - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai , The product will supply to all over the world, such as: Turkey, Swaziland, Venezuela, we sincerely hope to establish a good and long-term business relationship with your esteemed company through this opportunity, based on equality, mutual benefit and win-win business from now to the future. "Your satisfaction is our happiness".
  • In general, we are satisfied with all aspects, cheap, high-quality, fast delivery and good procuct style, we will have follow-up cooperation!
    5 Stars By Helen from Slovakia - 2018.08.12 12:27
    It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
    5 Stars By Madge from Houston - 2018.12.22 12:52
    Write your message here and send it to us